(ECOG) performance status (PS) and one patient had a PS of 0, five had a PS of 1, and four showed a PS of 2-4.
All of PICC insertions were performed by an expert interventional radiologist with fluoroscopic guidance. No patient was given prophylactic antibiotics or anticoagulation drugs for infection or thrombosis. The most common underlying disease was abdominal rhabdomyosarcoma (n=3, 33.3%). Lung cancer (n=2, 22.2%) and hematologic malignancies (n=2, 22.2%) were followed. No patients were complicated by diabetes mellitus.
Catheter characteristics and complications are shown in In performing chemotherapy, neither extravasation of drugs nor phlebitis was seen in this study.
Discussion
Extravasation of drugs is one of the most severe problems we should avoid in performing chemotherapy. It has been reported that the rate of extravasation during chemotherapy is 0.5-6.5%. Elderly, malnutrition, obesity or repeated chemotherapy are risk factors of extravasation 7) . Adverse events related to chemotherapy such as extravasation or phlebitis cause pain, delay of treatment and patients' distrust. We can presume elderly patients with cancer receiving chemotherapy increase year by year because of aging society.
Thus, clinicians should take further consideration for prevention of extravasation or phlebitis. Some demonstrated that PICC could help reduce incidence of cytotoxic drug extravasation-induced phlebitis and tissue necrosis 8) . We suggest that PICC should be considered in chemotherapy for cancer patients with a high risk of extravasation.
Venous punctures would be stressful for patients especially during chemotherapy where repeated ones are needed. While there is a costeffective problem, PICC could reduce burden for patients as well as for medical staffs by reducing the repeated puncture. 12) . No incidence of VTE, DVT were found in our study. We suggest that smaller PICCs could reduce complication of VTE and catheter size should be considered for prevention of VTE or DVT. We would recommend using 3 or 4 Fr catheters in chemotherapy, which doesn't make patients feel uncomfortable.
As for the frequency of catheter-related BSI in chemotherapy, it has been reported to be 0-25% 3, 13, 14) . Kim and Samaras, et al reported that a catheter-related BSI was seen more often in younger patients than in elder patients 15, 16) . One possible explanation is younger patients had more hematologic malignancies and tended to receive more intensive chemotherapy, resulting in neutropenia or leucopenia. Unfortunately, our study did not prove or disprove that a catheter is one of the risk factors of BSI in cancer chemotherapy, and more studies are necessary.
We have several limitations as follows. First, this was a retrospective analysis in a very small population. Second, there might have been a selection bias of the patients in this study as whether or not PICC was indicated by attending physicians.
Prospective study will be necessary and more cases are to be expected.
In conclusion, PICC would be one of the effective tools for the treatment of chemotherapy. We suggest that usage of PICC would reduce burden not only for patients but for medical staffs and the risk of complications upon chemotherapy. 
